Envestnet Portfolio Solutions Inc. Raises Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Envestnet Portfolio Solutions Inc. lifted its position in HCA Healthcare, Inc. (NYSE:HCA) by 14.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 15,623 shares of the company’s stock after buying an additional 2,002 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in HCA Healthcare were worth $4,689,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Evergreen Private Wealth LLC grew its position in shares of HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after buying an additional 35 shares during the last quarter. First Horizon Advisors Inc. boosted its stake in HCA Healthcare by 2.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock worth $623,000 after purchasing an additional 36 shares in the last quarter. Mediolanum International Funds Ltd boosted its stake in HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock worth $3,153,000 after purchasing an additional 36 shares in the last quarter. Hartford Funds Management Co LLC boosted its stake in HCA Healthcare by 1.6% in the 3rd quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock worth $1,003,000 after purchasing an additional 39 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. lifted its stake in HCA Healthcare by 6.1% during the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after acquiring an additional 40 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.5 %

NYSE HCA opened at $329.97 on Wednesday. The firm’s 50-day moving average is $320.07 and its two-hundred day moving average is $344.03. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The stock has a market capitalization of $81.24 billion, a P/E ratio of 15.02, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the company earned $5.90 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of several research reports. KeyCorp decreased their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $400.00 to $320.00 in a research note on Monday, November 25th. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Bank of America cut their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. Finally, Barclays cut their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.